US Stock MarketDetailed Quotes

PRLD Prelude Therapeutics

Watchlist
  • 1.300
  • +0.412+46.40%
Close Dec 20 16:00 ET
  • 1.280
  • -0.020-1.54%
Post 20:01 ET
71.55MMarket Cap-0.73P/E (TTM)

Prelude Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
3M
0
0
0
0
0
0
0
0
0
Operating revenue
--3M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.95%37.38M
14.71%37.16M
17.96%34.34M
7.07%132.28M
11.96%37.38M
9.80%33.39M
9.97%32.4M
-3.87%29.12M
8.62%123.54M
1.14%33.39M
Selling and administrative expenses
11.16%7.92M
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
-General and administrative expense
11.16%7.92M
3.00%7.66M
-4.77%6.93M
-5.76%28.88M
-6.24%7.05M
-5.23%7.12M
-8.82%7.43M
-2.49%7.28M
13.70%30.65M
-4.03%7.52M
Research and development costs
12.17%29.46M
18.20%29.51M
25.53%27.41M
11.31%103.39M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
7.04%92.89M
2.74%25.87M
Operating profit
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-7.07%-132.28M
-11.96%-37.38M
-9.80%-33.39M
-9.97%-32.4M
3.87%-29.12M
-8.62%-123.54M
-1.14%-33.39M
Net non-operating interest income expense
Other net income (expense)
-24.20%2.11M
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
Other non- operating income (expenses)
-24.20%2.11M
23.23%2.42M
108.45%2.91M
28.92%10.45M
-9.27%4.3M
519.87%2.78M
-5.75%1.97M
69.74%1.4M
296.96%8.1M
2,723.81%4.74M
Income before tax
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Income tax
Net income
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Net income continuous Operations
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Minority interest income
Net income attributable to the parent company
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-5.54%-121.83M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
-3.35%-115.44M
12.79%-28.64M
Basic earnings per share
4.44%-0.43
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
Diluted earnings per share
4.44%-0.43
14.81%-0.46
27.59%-0.42
17.21%-2.02
21.67%-0.47
28.57%-0.45
6.90%-0.54
7.94%-0.58
-0.41%-2.44
15.49%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 3M000000000
Operating revenue --3M--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.95%37.38M14.71%37.16M17.96%34.34M7.07%132.28M11.96%37.38M9.80%33.39M9.97%32.4M-3.87%29.12M8.62%123.54M1.14%33.39M
Selling and administrative expenses 11.16%7.92M3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M
-General and administrative expense 11.16%7.92M3.00%7.66M-4.77%6.93M-5.76%28.88M-6.24%7.05M-5.23%7.12M-8.82%7.43M-2.49%7.28M13.70%30.65M-4.03%7.52M
Research and development costs 12.17%29.46M18.20%29.51M25.53%27.41M11.31%103.39M17.25%30.33M14.73%26.26M17.16%24.97M-4.32%21.83M7.04%92.89M2.74%25.87M
Operating profit -2.97%-34.38M-14.71%-37.16M-17.96%-34.34M-7.07%-132.28M-11.96%-37.38M-9.80%-33.39M-9.97%-32.4M3.87%-29.12M-8.62%-123.54M-1.14%-33.39M
Net non-operating interest income expense
Other net income (expense) -24.20%2.11M23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M
Other non- operating income (expenses) -24.20%2.11M23.23%2.42M108.45%2.91M28.92%10.45M-9.27%4.3M519.87%2.78M-5.75%1.97M69.74%1.4M296.96%8.1M2,723.81%4.74M
Income before tax -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Income tax
Net income -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Net income continuous Operations -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Minority interest income
Net income attributable to the parent company -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.43%-32.27M-14.16%-34.74M-13.40%-31.43M-5.54%-121.83M-15.48%-33.08M-2.17%-30.61M-11.17%-30.43M5.93%-27.72M-3.35%-115.44M12.79%-28.64M
Basic earnings per share 4.44%-0.4314.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.6
Diluted earnings per share 4.44%-0.4314.81%-0.4627.59%-0.4217.21%-2.0221.67%-0.4728.57%-0.456.90%-0.547.94%-0.58-0.41%-2.4415.49%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%